• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Validated Stability Indicating RP-HPLC Method for the Determination of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir and Cobicistat in Pharmaceutical Dosage Form.一种用于测定药物剂型中恩曲他滨、替诺福韦酯富马酸盐、埃替格韦和考比司他的经验证的稳定性指示反相高效液相色谱法。
J Chromatogr Sci. 2016 May-Jun;54(5):759-64. doi: 10.1093/chromsci/bmw004. Epub 2016 Feb 9.
2
UPLC-PDA Approach for Simultaneous Quantification of Elvitegravir, Tenofovir, Emtricitabine and Cobicistat in Tablets: An MS-ESI Study for Degradation Products.UPLC-PDA 法同时测定片剂中艾维雷韦、替诺福韦、恩曲他滨和考比司他的含量:用于降解产物的 MS-ESI 研究。
J Chromatogr Sci. 2024 Oct 1;62(8):719-731. doi: 10.1093/chromsci/bmad067.
3
Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid.建立并验证人血浆和脑脊液中替诺福韦和替诺福韦艾拉酚胺的 LC-MS/MS 检测方法。
J Pharm Biomed Anal. 2018 Jul 15;156:163-169. doi: 10.1016/j.jpba.2018.04.035. Epub 2018 Apr 23.
4
Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms.同时测定药物剂型中含恩曲他滨、富马酸替诺福韦二吡呋酯和盐酸利匹韦林的HIV片剂的稳定性指示高效液相色谱法
Int Sch Res Notices. 2014 Oct 29;2014:849149. doi: 10.1155/2014/849149. eCollection 2014.
5
RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.反相高效液相色谱法同时测定片剂中富马酸比索洛尔和氢氯噻嗪的含量。
J Pharm Biomed Anal. 2010 Jul 8;52(3):362-71. doi: 10.1016/j.jpba.2009.10.021. Epub 2009 Oct 31.
6
Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC.反相高效液相色谱法同时测定盐酸二甲双胍和维格列汀的经验证的稳定性指示测定方法的开发。
Drug Res (Stuttg). 2014 Mar;64(3):124-9. doi: 10.1055/s-0033-1354373. Epub 2013 Sep 19.
7
A validated stability-indicating liquid chromatographic method for the determination of retapamulin in topical dosage form.一种用于测定局部用剂型中瑞他帕林的经验证的稳定性指示液相色谱法。
J Chromatogr Sci. 2014 Mar;52(3):238-45. doi: 10.1093/chromsci/bmt018. Epub 2013 Mar 19.
8
A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets.一种简单的用于同时分析富马酸替诺福韦二吡呋酯、多伟拉韦和拉米夫定的稳定性指示反相高效液相色谱-二极管阵列检测法,用于纯混合物及其复方薄膜包衣片剂的分析。
Ann Pharm Fr. 2021 Nov;79(6):640-651. doi: 10.1016/j.pharma.2021.04.006. Epub 2021 May 19.
9
Stability-indicating LC-UV method for the determination of eszopiclone and degradation impurities in tablet dosage form.用于测定片剂剂型中艾司佐匹克隆及其降解杂质的稳定性指示液相色谱-紫外检测法
J Chromatogr Sci. 2014 Apr;52(4):293-7. doi: 10.1093/chromsci/bmt027. Epub 2013 Apr 3.
10
A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.一种经过验证的用于安立生坦及其相关物质的特定稳定性指示反相高效液相色谱测定方法。
J Chromatogr Sci. 2014 Sep;52(8):818-25. doi: 10.1093/chromsci/bmt121. Epub 2013 Aug 7.

引用本文的文献

1
Sensitive RP-HPLC method with fluorimetric detection for concurrent quantification of emtricitabine, Daclatasvir and Ledipasvir in human urine.采用荧光检测的灵敏反相高效液相色谱法同时定量测定人尿中的恩曲他滨、达卡他韦和雷迪帕韦。
Sci Rep. 2025 Jul 1;15(1):22393. doi: 10.1038/s41598-025-07401-y.
2
Fabrication of a Double Core-Shell Particle-Based Magnetic Nanocomposite for Effective Adsorption-Controlled Release of Drugs.用于药物有效吸附-控释的基于双核壳颗粒的磁性纳米复合材料的制备
Polymers (Basel). 2022 Jun 30;14(13):2681. doi: 10.3390/polym14132681.

本文引用的文献

1
Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors.考比司他:一种新型药物共调剂,可与 HIV 蛋白酶和整合酶抑制剂联合使用。
Infect Dis Ther. 2013 Dec;2(2):111-22. doi: 10.1007/s40121-013-0013-7. Epub 2013 Sep 3.
2
Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection.考比司他:作为一种药代动力学增强剂在 HIV-1 感染患者中应用于阿扎那韦和达芦那韦的评价。
Drugs. 2014 Feb;74(2):195-206. doi: 10.1007/s40265-013-0160-x.
3
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.恩曲他滨、替诺福韦、考比司他与艾维雷韦、恩曲他滨、替诺福韦复方制剂用于初治 HIV-1 感染:一项随机、双盲、III 期临床试验,48 周后结果分析。
Lancet. 2012 Jun 30;379(9835):2439-2448. doi: 10.1016/S0140-6736(12)60917-9.
4
Resistance to HIV-1 integrase inhibitors: A structural perspective.HIV-1 整合酶抑制剂耐药性:结构视角。
Drug Resist Updat. 2010 Aug-Oct;13(4-5):139-50. doi: 10.1016/j.drup.2010.05.001. Epub 2010 Jun 8.
5
HPTLC Method for the Simultaneous Estimation of Emtricitabine and Tenofovir in Tablet Dosage Form.高效薄层色谱法同时测定片剂剂型中恩曲他滨和替诺福韦的含量
Indian J Pharm Sci. 2009 Jan;71(1):95-7. doi: 10.4103/0250-474X.51951.
6
Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial.艾维雷格(elvitegravir),一种每日一次的整合酶抑制剂,对耐药 HIV-1 的活性:一项 2 期、随机、对照、剂量范围的临床试验结果。
J Infect Dis. 2010 Mar 15;201(6):814-22. doi: 10.1086/650698.
7
Integrase inhibitors: a novel class of antiretroviral agents.整合酶抑制剂:一类新型的抗逆转录病毒药物。
Ann Pharmacother. 2010 Jan;44(1):145-56. doi: 10.1345/aph.1M309. Epub 2009 Dec 29.
8
Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus.恩曲他滨,一种对HIV和乙型肝炎病毒具有活性的新型抗逆转录病毒药物。
Clin Infect Dis. 2006 Jan 1;42(1):126-31. doi: 10.1086/498348. Epub 2005 Nov 23.
9
Emtricitabine: an antiretroviral agent for HIV infection.恩曲他滨:一种用于治疗HIV感染的抗逆转录病毒药物。
Drugs. 2003;63(22):2413-24; discussion 2425-6. doi: 10.2165/00003495-200363220-00003.
10
Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.富马酸替诺福韦二吡呋酯:一种用于治疗HIV感染的核苷酸逆转录酶抑制剂。
Clin Ther. 2002 Oct;24(10):1515-48. doi: 10.1016/s0149-2918(02)80058-3.

一种用于测定药物剂型中恩曲他滨、替诺福韦酯富马酸盐、埃替格韦和考比司他的经验证的稳定性指示反相高效液相色谱法。

A Validated Stability Indicating RP-HPLC Method for the Determination of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir and Cobicistat in Pharmaceutical Dosage Form.

作者信息

Runja Chinnalalaiah, Kumar Pigili Ravi, Avanapu Srinivasa Rao

机构信息

Department of Pharmaceutical Chemistry, Joginpally B.R. Pharmacy College, Moinabad, Hyderabad 500 075, Telangana, India

Aizant Drug Research Solutions, Hyderabad 500 014, Telangana, India.

出版信息

J Chromatogr Sci. 2016 May-Jun;54(5):759-64. doi: 10.1093/chromsci/bmw004. Epub 2016 Feb 9.

DOI:10.1093/chromsci/bmw004
PMID:26865655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4890450/
Abstract

A new simple, rapid stability indicating assay method has been developed and validated for the determination of emtricitabine, tenofovir disoproxil fumarate, elvitegravir and cobicistat using reverse-phase high-performance liquid chromatography in their pharmaceutical dosage form. The chromatographic separation was performed on an ODS column (250 × 4.6 mm, 5 µm) using mobile phase A (potassium dihydrogen orthophosphate, pH adjusted to 2.5) and mobile phase B (acetonitrile) in the ratio of 55:45% v/v at a flow rate of 1 mL/min. The analytes were detected at 250 nm. The method was found to be linear in the concentration range of 2-12 µg/mL for EMT, 3-18 µg/mL for TNDF, 1.5-9 µg/mL for ELV and COB, with the coefficient value (R(2)) of >0.9990. The accuracy was measured via recovery studies and found to be acceptable, and the percentage recoveries were found in the range of 99.93-100.08 ± 0.5%. Forced degradation studies were also conducted, and the drugs were subjected to various stress conditions such as acid hydrolysis, base hydrolysis, oxidative, photolytic and thermal degradation. The proposed method was successfully validated and applied for the quantitative estimation of these drugs in both bulk and tablet dosage forms.

摘要

已开发并验证了一种新的简单、快速的稳定性指示测定方法,用于采用反相高效液相色谱法测定其药物剂型中的恩曲他滨、替诺福韦酯富马酸盐、埃替格韦和考比司他。色谱分离在ODS柱(250×4.6 mm,5 µm)上进行,使用流动相A(磷酸二氢钾,pH值调至2.5)和流动相B(乙腈),比例为55:45% v/v,流速为1 mL/min。在250 nm处检测分析物。该方法在恩曲他滨(EMT)浓度范围为2 - 12 µg/mL、替诺福韦酯富马酸盐(TNDF)为3 - 18 µg/mL、埃替格韦(ELV)和考比司他(COB)为1.5 - 9 µg/mL时呈线性,系数值(R(2))>0.9990。通过回收率研究测量准确度,发现其可接受,回收率百分比在99.93 - 100.08 ± 0.5%范围内。还进行了强制降解研究,使药物经受各种应力条件,如酸水解、碱水解、氧化降解、光解降解和热降解。所提出的方法成功得到验证,并应用于原料药和片剂剂型中这些药物的定量测定。